FDA warns people to avoid using some forms of compounded substitutes of semaglutides that lack the safety and efficacy of popular weight loss drugs Wegovy, Ozempic, and...
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
26 readers recommended
Reduce heart failure risk with FDA-approved Inpefa (sotagliflozin). Inhibiting SGLT-2 and SGLT-1, it outshines other medications. Learn more about its effectiveness and...
6 readers recommended
In case you missed them, here are our top stories from May 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings...
27 readers recommended
Oculis' OCS-01 eye drops show promising results in phase 3 trials for diabetic macular edema treatment. Uncover a potential revolution in non-invasive eye care solutions.
31 readers recommended
Early findings from a phase 3 clinical trial demonstrated that participants treated with 50 mg oral semaglutide achieved a remarkable weight loss of 17.4%. This research...
39 readers recommended
Farxiga (dapagliflozin), a SGLT-2 inhibitor, has officially been approved by the FDA to treat all types of heart failure, a common diabetes complication.
178 readers recommended
Eli Lilly’s SURMOUNT-2 trial clinical trial results show substantial weight loss in people with type 2 diabetes taking Mounjaro (tirzepatide) at high doses, positioning...
25 readers recommended
The FDA has cleared the Omnipod GO: a discreet, water-resistant insulin pod with up to 3 days of wear. Enjoy the freedom and convenience to manage your diabetes.
46 readers recommended
The FDA recently cleared a new experimental drug for type 1 diabetes to begin a phase 2 clinical trial. If approved, the drug would be the first therapy to specifically...
91 readers recommended
Researchers released clinical trial data on a new treatment for type 2 diabetes that may help the body’s insulin-producing cells regenerate. 78% of the clinical trial’s...
66 readers recommended
Mark Cuban’s Cost Plus Drug Company recently added SGLT-2 inhibitor Invokana to its list of available medications. The company, which uses an innovative business model...
27 readers recommended
California Gov. Gavin Newsom announced a $50-million contract with Civica Rx to produce the state’s own insulin, adding to the recent new policies aiming to make this...
54 readers recommended
Novo Nordisk’s PIONEER PLUS trial has delivered promising A1C and weight loss results for patients with type 2 diabetes taking the oral semaglutide Rybelsus at...
17 readers recommended
Tandem Diabetes announced clinical trial results that showed from the very first day, children with type 1 diabetes who used the Control-IQ hybrid closed loop technology...
23 readers recommended
A clinical trial is recruiting participants with type 2 diabetes and chronic kidney disease (CKD) to see how well a combination of glucose-lowering and kidney-protective...
37 readers recommended
Following Eli Lilly’s recent announcement of a $35 monthly limit on out-of pocket costs, Sanofi announced a $35 cost cap on Lantus, and Novo Nordisk pledged to reduce...
109 readers recommended
Eli Lilly announced today that it will cut the list prices for its most commonly prescribed insulins, including Humalog and Humulin, by 70%. The drug maker will also...
234 readers recommended
At ATTD 2023, a panel of experts discussed the latest medications for weight loss and the treatment of obesity. The panel highlighted two FDA approved drugs, as well as...
29 readers recommended
The low-cost drug verapamil, a widely available generic drug for blood pressure, was shown to preserve insulin-producing beta cell function in young people, aged 7-17,...
67 readers recommended
Researchers at this week’s 2023 Advanced Technologies and Treatments for Diabetes (ATTD) conference in Berlin provided an update on icodec and efsitora, two new basal...